Studies are underway to determine if gene-editing can be used to fix high cholesterol. Some reports indicate that a gene-editing therapy has safely lowered cholesterol and triglycerides in a first-in-human trial, with one study suggesting harmful cholesterol levels were cut in half. The outcomes of these studies are being reported, but the details and implications of the research are still emerging.